Macrophage PPARγ and impaired wound healing in type 2 diabetes

Journal of Pathology

Volumn 236, Issue 4, 2015, Pages 433-444

  Mirza, Rita E ^a   Fang, Milie M ^a   Novak, Margaret L ^a   Urao, Norifumi ^a   Sui, Audrey ^a   Ennis, William J ^a   Koh, Timothy J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

diabetes; inflammation; macrophage; resolution of inflammation; wound healing

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE I; CD36 ANTIGEN; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; 15-DEOXYPROSTAGLANDIN J2; 2,4 THIAZOLIDINEDIONE DERIVATIVE; IL1B PROTEIN, HUMAN; IL1B PROTEIN, MOUSE; IL1R1 PROTEIN, MOUSE; INTERLEUKIN 1 RECEPTOR TYPE I; PROSTAGLANDIN D2; ROSIGLITAZONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; T LYMPHOCYTE; UPREGULATION; WOUND HEALING IMPAIRMENT; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CELL CULTURE; DEFICIENCY; DIABETES MELLITUS, TYPE 1; DISEASE MODEL; DRUG EFFECTS; GENETICS; INTRADERMAL DRUG ADMINISTRATION; KNOCKOUT MOUSE; LEG ULCER; METABOLISM; PATHOLOGY; SKIN; TIME; WOUND HEALING;

ADMINISTRATION, CUTANEOUS; ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INTERLEUKIN-1BETA; LEG ULCER; MACROPHAGES; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENOTYPE; PPAR GAMMA; PROSTAGLANDIN D2; RECEPTORS, INTERLEUKIN-1 TYPE I; SKIN; THIAZOLIDINEDIONES; TIME FACTORS; WOUND HEALING;

EID: 84937516501     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4548     Document Type: Article

References (59)

1. Ramasamy R, Yan SF, Schmidt AM,. Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications. Ann NY Acad Sci 2011; 1243: 88-102.
2. Hill MJ, Metcalfe D, McTernan PG,. Obesity and diabetes: lipids, 'nowhere to run to'. Clin Sci (Lond) 2009; 116: 113-123.
3. Jin C, Flavell RA,. Innate sensors of pathogen and stress: linking inflammation to obesity. J Allergy Clin Immunol 2013; 132: 287-294.
4. Maskrey BH, Megson IL, Whitfield PD, et al., Mechanisms of resolution of inflammation: a focus on cardiovascular disease. Arterioscler Thromb Vasc Biol 2011; 31: 1001-1006.
5. Spite M, Claria J, Serhan CN,. Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases. Cell Metab 2014; 19: 21-36.
6. Chawla A., Control of macrophage activation and function by PPARs. Circ Res 2010; 106: 1559-1569.
7. Straus DS, Glass CK,. Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol 2007; 28: 551-558.
8. Lehrke M, Lazar MA,. The many faces of PPAR-γ. Cell 2005; 123: 993-999.
9. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, et al., Macrophage-specific PPARγ controls alternative activation and improves insulin resistance. Nature 2007; 447: 1116-1120.
10. -/- bone marrow. J Lipid Res 2009; 50: 214-224.
11. Goren I, Allmann N, Yogev N, et al., A transgenic mouse model of inducible macrophage depletion: effects of diphtheria toxin-driven lysozyme M-specific cell lineage ablation on wound inflammatory, angiogenic, and contractive processes. Am J Pathol 2009; 175: 132-147.
12. Lucas T, Waisman A, Ranjan R, et al., Differential roles of macrophages in diverse phases of skin repair. J Immunol 2010; 184: 3964-3977.
13. Mirza R, DiPietro LA, Koh TJ,. Selective and specific macrophage ablation is detrimental to wound healing in mice. Am J Pathol 2009; 175: 2454-2462.
14. Bannon P, Wood S, Restivo T, et al., Diabetes induces stable intrinsic changes to myeloid cells that contribute to chronic inflammation during wound healing in mice. Dis Model Mech 2013; 6: 1434-1447.
15. Khanna S, Biswas S, Shang Y, et al., Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS One 2010; 5: e9539.
16. Mirza R, Koh TJ,. Dysregulation of monocyte/macrophage phenotype in wounds of diabetic mice. Cytokine 2011; 56: 256-264.
17. Wetzler C, Kampfer H, Stallmeyer B, et al., Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 2000; 115: 245-253.
18. Tian H, Lu Y, Shah SP, et al., Autacoid 14S,21R-dihydroxy-docosahexaenoic acid counteracts diabetic impairment of macrophage prohealing functions. Am J Pathol 2011; 179: 1780-1791.
19. hi macrophage population promoting wound healing. J Invest Dermatol 2013; 133: 783-792.
20. Mirza RE, Fang MM, Ennis WJ, et al., Blocking interleukin-1β induces a healing-associated wound macrophage phenotype and improves healing in type 2 diabetes. Diabetes 2013; 62: 2579-2587.
21. Mirza RE, Fang MM, Weinheimer-Haus EM, et al., Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice. Diabetes 2014; 63: 1103-1114.
22. Akiyama TE, Sakai S, Lambert G, et al., Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux. Mol Cell Biol 2002; 22: 2607-2619.
23. Jiang C, Ting AT, Seed B,. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 1998; 391: 82-86.
24. Ricote M, Li AC, Willson TM, et al., The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 1998; 391: 79-82.
25. Welch JS, Ricote M, Akiyama TE, et al., PPARγ and PPARδ negatively regulate specific subsets of lipopolysaccharide and IFNγ target genes in macrophages. Proc Natl Acad Sci USA 2003; 100: 6712-6717.
26. -ΔΔC t method. Methods 2001; 25: 402-408.
27. Szanto A, Balint BL, Nagy ZS, et al., STAT6 transcription factor is a facilitator of the nuclear receptor PPARγ-regulated gene expression in macrophages and dendritic cells. Immunity 2010; 33: 699-712.
28. Huang JT, Welch JS, Ricote M, et al., Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase. Nature 1999; 400: 378-382.
29. Vats D, Mukundan L, Odegaard JI, et al., Oxidative metabolism and PGC-1β attenuate macrophage-mediated inflammation. Cell Metab 2006; 4: 13-24.
30. Mirza RE, Koh TJ,. Contributions of cell subsets to cytokine production during normal and impaired wound healing. Cytokine 2015; 71: 409-412.
31. Namgaladze D, Lips S, Leiker TJ, et al., Inhibition of macrophage fatty acid β-oxidation exacerbates palmitate-induced inflammatory and endoplasmic reticulum stress responses. Diabetologia 2014; 57: 1067-1077.
32. Afif H, Benderdour M, Mfuna-Endam L, et al., Peroxisome proliferator-activated receptor-γ1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1β in articular chondrocytes. Arthritis Res Ther 2007; 9: R31.
33. Daley JM, Brancato SK, Thomay AA, et al., The phenotype of murine wound macrophages. J Leukoc Biol 2010; 87: 59-67.
34. Freire-de-Lima CG, Xiao YQ, Gardai SJ, et al., Apoptotic cells, through transforming growth factor-β, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages. J Biol Chem 2006; 281: 38376-38384.
35. Kotlinowski J, Grochot-Przeczek A, Taha H, et al., PPARγ activation but not PPARγ haplodeficiency affects proangiogenic potential of endothelial cells and bone marrow-derived progenitors. Cardiovasc Diabetol 2014; 13: 150.
36. Liao H, Pastar I, Chen W,. Rosiglitazone modulates the behaviors of diabetic host-derived fibroblasts in a carboxymethyllysine-modified collagen model. Wound Repair Regen 2012; 20: 435-443.
37. Kapoor M, Kojima F, Yang L, et al., Sequential induction of pro- and anti-inflammatory prostaglandins and peroxisome proliferators-activated receptor-γ during normal wound healing: a time course study. Prostagland Leukot Essent Fatty Acids 2007; 76: 103-112.
38. Gautier EL, Chow A, Spanbroek R, et al., Systemic analysis of PPARγ in mouse macrophage populations reveals marked diversity in expression with critical roles in resolution of inflammation and airway immunity. J Immunol 2012; 189: 2614-2624.
39. Hasegawa-Moriyama M, Ohnou T, Godai K, et al., Peroxisome proliferator-activated receptor-γ agonist rosiglitazone attenuates postincisional pain by regulating macrophage polarization. Biochem Biophys Res Commun 2012; 426: 76-82.
40. Das LM, Rosenjack J, Au L, et al., Hyper-inflammation and skin destruction mediated by rosiglitazone activation of macrophages in IL-6 deficiency. J Invest Dermatol 2015; 135: 389-399.
41. Mao-Qiang M, Fowler AJ, Schmuth M, et al., Peroxisome-proliferator-activated receptor (PPAR)-γ activation stimulates keratinocyte differentiation. J Invest Dermatol 2004; 123: 305-312.
42. Chong HC, Tan MJ, Philippe V, et al., Regulation of epithelial-mesenchymal IL-1 signaling by PPARβ/δ is essential for skin homeostasis and wound healing. J Cell Biol 2009; 184: 817-831.
43. Michalik L, Desvergne B, Tan NS, et al., Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)α and PPARβ mutant mice. J Cell Biol 2001; 154: 799-814.
44. Straus DS, Pascual G, Li M, et al., 15-deoxy-δ12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway. Proc Natl Acad Sci USA 2000; 97: 4844-4849.
45. Shapiro H, Lutaty A, Ariel A,. Macrophages, meta-inflammation, and immuno-metabolism. Sci World J 2011; 11: 2509-2529.
46. O'Neill LA, Hardie DG,. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 2013; 493: 346-355.
47. Mounier R, Theret M, Arnold L, et al., AMPKα1 regulates macrophage skewing at the time of resolution of inflammation during skeletal muscle regeneration. Cell Metab 2013; 18: 251-264.
48. Blakytny R, Jude E,. The molecular biology of chronic wounds and delayed healing in diabetes. Diabet Med 2006; 23: 594-608.
49. Greenhalgh DG, Sprugel KH, Murray MJ, et al., PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol 1990; 136: 1235-1246.
50. Lobmann R, Ambrosch A, Schultz G, et al., Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 2002; 45: 1011-1016.
51. Mast BA, Schultz GS,. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen 1996; 4: 411-420.
52. Mirza RE, Koh TJ,. Contributions of cell subsets to cytokine production during normal and impaired wound healing. Cytokine 2015; 71: 409-412.
53. Rodgers KE, Ellefson DD, Espinoza T, et al., Expression of intracellular filament, collagen, and collagenase genes in diabetic and normal skin after injury. Wound Repair Regen 2006; 14: 298-305.
54. Sindrilaru A, Peters T, Wieschalka S, et al., An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest 2011; 121: 985-997.
55. Trengove NJ, Bielefeldt-Ohmann H, Stacey MC,. Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Repair Regen 2000; 8: 13-25.
56. Trengove NJ, Langton SR, Stacey MC,. Biochemical analysis of wound fluid from nonhealing and healing chronic leg ulcers. Wound Repair Regen 1996; 4: 234-239.
57. Nissen SE, Wolski K,. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 2007; 356: 2457-2471.
58. Diamond GA, Bax L, Kaul S,. Uncertain effects of rosiglitazone on the risk for myocardial infarction and cardiovascular death. Ann Intern Med 2007; 147: 578-581.
59. Chen H, Shi R, Luo B, et al., Macrophage peroxisome proliferator-activated receptor-γ deficiency delays skin wound healing through impairing apoptotic cell clearance in mice. Cell Death Dis 2015; 6: e1597.